Dupont Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Dupont Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,900	Closed	-$1.73M	–	1451
2019 Q4	$1.73M	Sell	28,900 -12,696	-31%	-$477K	0.04%	387
2019 Q3	$1.17M	Buy	41,596 +21,916	+111%	+$748K	0.03%	479
2019 Q2	$745K	Buy	+19,680	New	+$756K	0.02%	633

Dupont Capital Management's BOLD Position: Q1 2020 in Review

Dupont Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 28,900 shares — an estimated $1.73M sold.

Dupont Capital Management first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $1.73M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Dupont Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Dupont Capital Management sold 28,900 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.73M.
Dupont Capital Management first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
Dupont Capital Management's Audentes Therapeutics, Inc position peaked at $1.73M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Dupont Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.